Craneware (LON:CRW – Get Free Report)‘s stock had its “buy” rating reaffirmed by Berenberg Bank in a research report issued on Tuesday, MarketBeat Ratings reports. They presently have a GBX 2,800 ($36.31) price target on the stock. Berenberg Bank’s price target would indicate a potential upside of 57.30% from the company’s current price.
Separately, Shore Capital reiterated a “buy” rating on shares of Craneware in a report on Tuesday.
View Our Latest Research Report on Craneware
Craneware Stock Up 0.6 %
About Craneware
The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.
Featured Stories
- Five stocks we like better than Craneware
- The Risks of Owning Bonds
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- 3 Warren Buffett Stocks to Buy Now
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- How to Start Investing in Real Estate
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.